×
About 7,508 results
Commonly Abused Drugs Charts
https://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-charts
NIH

Nov 9th, 2019 - Many misused drugs can alter a person’s thinking and judgment, leading to health risks, including addiction, drugged driving and infectious disease. Most drugs could potentially harm an unborn baby; pregnancy-related issues are listed in the chart below for drugs where there is enough scientific evidence to connect the drug use to specific negative effects. Commonly Abused Drugs.

MORPHABOND (morphine sulfate) extended-release tablets Prescribing Information
http://inspiriondt.com/wp-content/uploads/2012/08/MorphaBond-PI-02Oct2015.pdf

Oct 30th, 2015 - Assess each patient's risk for opioid addiction, abuse, or misuse prior to prescribing MORPHABOND, and monitor all patients receiving MORPHABOND for development of these behaviors or conditions. ... Although the risk of addiction in any individual is unknown, it can occur in patients appropriately prescribed MORPHABOND.

ABILIFY MAINTENA® (aripiprazole) injection
https://abilifymaintenahcp.com/

ABILIFY MAINTENA for the treatment of schizophrenia and the maintenance treatment of bipolar I disorder in adult patients. See full Safety and Prescribing Information, including BOXED WARNING.

ADDERALL XR®
http://www.shirecontent.com/PI/PDFS/AdderallXR_USA_ENG.PDF

ADDERALL XR, a CNS stimulant, is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

ARICEPT® (donepezil HCl) tablets
https://www.pfizer.com/products/product-detail/aricept

ARICEPT U.S. Physician Prescribing Information · ARICEPT U.S. Medical Information Page - clinical & safety information, ways to contact Pfizer Medical & other ...

APTENSIO XR® (methylphenidate HCI Extended Release)
http://aptensioxr.com/hcp/

Once-daily Aptensio XR is for the treatment of ADHD. Learn about the risks and benefits of Aptensio XR.

BELSOMRA® (suvorexant)
https://www.merckconnect.com/belsomra/overview.html

Health care professionals can access resources and find information about BELSOMRA® (suvorexant) C-IV at MerckConnect.com.

DYANAVEL® XR (amphetamine)
http://dyanavelxrpro.com

Dyanavel XR's approval was based on a laboratory classroom study conducted in 108 children (6 – 12 years of age) with ADHD. The attention and behavior of the subjects were evaluated using the Swanson,. Kotkin, Agler, M-Flynn, and Pelham (SKAMP) rating scale.

Depakote® (divalproex sodium)
https://www.depakote.com/hcp

When Depakote (divalproex sodium) tablets, for oral use, Depakote ER (divalproex sodium) extended-release tablets, for oral use, or Depakote Sprinkle Capsules (divalproex sodium delayed release capsules), for oral use, is used in this patient group, it should be used with extreme ...

BUNAVAIL® (buprenorphine and naloxone) BUCCAL FILM
http://bunavail.com/hcp/

BUNAVAIL (buprenorphine and naloxone) buccal film is a citrus flavored oral transmucosal form of buprenorphine, an opioid partial agonist, and naloxone, an opioid antagonist, intended for application to the buccal mucosa.

CONCERTA® (methylphenidate HCl) Extended-release Tablets CII
https://www.concerta.net/

Learn about ADHD in Children and Adults, treatment options, and how CONCERTA? can help manage ADHD symptoms.

FETZIMA (levomilnacipran) extended-release capsules
http://www.fetzimahcp.com/

Choose FETZIMA® as a treatment for your appropriate adult MDD patients. See safety info, including Boxed Warning & full Prescribing Information.

GUANFACINE EXTENDED RELEASE TABLETS
https://www.tevagenerics.com/product/guanfacine-extended-release-tablets

Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications

FORFIVO XL® (bupropion hydrochloride) TABLETS
http://www.forfivoxl.com/

You can titrate to higher doses without adding more pills. Patients can be titrated up to Forfivo XL 450 mg once daily if they have been taking 300 mg per day of bupropion for at least 2 weeks and require a dosage of 450 mg per day.

REXULTI® (brexpiprazole) tablets
https://rexultihcp.com

See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

NARCAN NASAL SPRAY
https://www.narcan.com/healthcare-professional

Information for prescribers about the organizations and Surgeon General advice to co-prescribe naloxone to patients who will have opioids. Also includes the Surgeon General’s speech on opioids and co-prescribing naloxone.

EFFEXOR XR® (venlafaxine HCl) Extended-Release Capsules
https://www1.pfizerpro.com/product/effexorxr/hcp

Indications: Effexor XR extended-release capsules are indicated for the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and Panic Disorder (PD) with or without agoraphobia. ... Effexor XR is not approved for use in ...

EQUETRO® (carbamazepine) EXTENDED-RELEASE CAPSULES
http://equetro.com/professionals

Equetro is the only form of carbamazepine that has all three of these .... on the registry can also be found at the website http://www.aedpregnancyregistry.org.

DULOXETINE DR
http://camberpharma.com/products/duloxetine-307

Duloxetine is indicated for the treatment of: Major Depressive Disorder; Generalized Anxiety Disorder; Diabetic Peripheral Neuropathy; Fibromyalgia; Chronic Musculoskeletal Pain

EVEKEO® (amphetamine sulfate tablets, USP)
https://www.evekeo.com/hcp

Physicians seeking information about EVEKEO CII (amphetamine sulfate), visit the official HCP website here. See full safety and abuse information.